期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Enhancing Startup Financing Success Prediction Using Topic Based Deep Neural Networks
1
作者 Zhen QIU Yifan QU +2 位作者 shaochen yang Wei XU Hong ZHAO 《Journal of Systems Science and Information》 2025年第4期600-618,共19页
In the modern economy,startups are not only significant drivers of innovation and technological progress but also key players in addressing employment issues and promoting economic diversification.However,startups oft... In the modern economy,startups are not only significant drivers of innovation and technological progress but also key players in addressing employment issues and promoting economic diversification.However,startups often face substantial operational risks and uncertainties in their early stages,especially regarding financing.To uncover the impact of different resource allocations and strategic choices on financing success,this study proposes a predictive method based on the latent Dirichlet allocation(LDA)topic model and deep neural networks through an in-depth analysis of startup financing cases.We systematically collected description text data from 2,000 startups and extracted text features from these descriptions using the LDA topic model.These features,combined with several traditional numerical indicators such as industry,product type,technology type,number of employees,and company size,were used to train a deep neural network to predict startup financing outcomes.The experimental results show that the prediction performance based on the LDA topic model is significantly better than that of traditional models relying solely on numerical data.This highlights the importance of text features in predicting the success of startup financing. 展开更多
关键词 STARTUP financing success prediction LDA topic model
原文传递
Distinct demethylation pathways of rice-and fish-derived methylmercury in pregnant women revealed by compound-specific isotope analysis
2
作者 Chuyan Lai shaochen yang +5 位作者 Ruolan Li Huifang Jiang Rasheed Mohammed Abdul Ping Li Bo Wang Xinbin Feng 《Eco-Environment & Health》 2026年第1期47-54,共8页
Understanding mercury(Hg)metabolism and exposure pathways in pregnant women is essential for protecting fetal health.However,most previous studies have relied primarily on Hg concentrations in single biomarkers,limiti... Understanding mercury(Hg)metabolism and exposure pathways in pregnant women is essential for protecting fetal health.However,most previous studies have relied primarily on Hg concentrations in single biomarkers,limiting insight into in vivo metabolic differences and maternal-fetal transfer,especially regarding source-specific MeHg metabolism.This study applies compound-specific stable isotope analysis to investigate total Hg(THg)and methylmercury(MeHg)concentrations and isotopic signatures in rice and maternal biomarkers from the Wanshan Hg mining area,China.Widespread mass-dependent fractionation(MDF)was observed across different biomarkers.The MDF of THg was driven by internal redistribution and demethylation of MeHg,while the MDF of MeHg specifically reflected metabolic demethylation processes in the gut and brain.In contrast,no mass-independent fractionation(MIF)was observed during maternal or transplacental THg transfer,suggesting thatΔ199Hg values in maternal biomarkers reflect food-source signals.This study identifies the biomarker-specific contribution of dietary sources:MeHg isotope mixing models revealed that rice contributed a higher proportion of Hg in maternal blood than in hair,comparable to that in placenta and cord blood.Comparisons with previously reported fish-derived MeHg isotopes suggest that rice-derived MeHg undergoes preferential demethylation and elimination,highlighting the complexity of in vivo Hg dynamics.The use of both THg and MeHg isotopes in biomarkers enables more precise tracing of dietary Hg sources.These findings highlight the value of multi-biomarker isotope analysis for tracing Hg sources and improving exposure assessments. 展开更多
关键词 Prenatal exposure Methylmercury Demethylation Mercury isotope Metabolic process
在线阅读 下载PDF
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy 被引量:4
3
作者 Xianbin Ma shaochen yang +9 位作者 Tian Zhang Shuo Wang Qichao yang Yao Xiao Xiaoxiao Shi Peng Xue Yuejun Kang Gang Liu Zhi-Jun Sun Zhigang Xu 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第1期451-466,共16页
The combination of chemotherapy and immunotherapy motivates a potent immune system by triggering immunogenic cell death(ICD), showing great potential in inhibiting tumor growth and improving the immunosuppressive tumo... The combination of chemotherapy and immunotherapy motivates a potent immune system by triggering immunogenic cell death(ICD), showing great potential in inhibiting tumor growth and improving the immunosuppressive tumor microenvironment(ITM). However, the therapeutic effectiveness has been restricted by inferior drug bioavailability. Herein, we reported a universal bioresponsive doxorubicin(DOX)-based nanogel to achieve tumor-specific co-delivery of drugs. DOX-based mannose nanogels(DM NGs) was designed and choosed as an example to elucidate the mechanism of combined chemo-immunotherapy. As expected, the DM NGs exhibited prominent micellar stability, selective drug release and prolonged survival time, benefited from the enhanced tumor permeability and prolonged blood circulation. We discovered that the DOX delivered by DM NGs could induce powerful antitumor immune response facilitated by promoting ICD. Meanwhile, the released mannose from DM NGs was proved as a powerful and synergetic treatment for breast cancer in vitro and in vivo, via damaging the glucose metabolism in glycolysis and the tricarboxylic acid cycle. Overall, the regulation of tumor microenvironment with DOX-based nanogel is expected to be an effectual candidate strategy to overcome the current limitations of ICD-based immunotherapy, offering a paradigm for the exploitation of immunomodulatory nanomedicines. 展开更多
关键词 Bioresponsive PRODRUG NANOGEL DOXORUBICIN MANNOSE Immunogenic cell death Chemotherapy Immunotherapy
原文传递
Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity 被引量:1
4
作者 Qichao yang Xianbin Ma +8 位作者 Yao Xiao Tian Zhang Leilei yang shaochen yang Mengyun Liang Shuo Wang Zhizhong Wu Zhigang Xu Zhijun Sun 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第7期3139-3155,共17页
Aberrant activation of oncogenic signaling pathways in tumors can promote resistance to the antitumor immune response.However,single blockade of these pathways is usually ineffective because of the complex crosstalk a... Aberrant activation of oncogenic signaling pathways in tumors can promote resistance to the antitumor immune response.However,single blockade of these pathways is usually ineffective because of the complex crosstalk and feedback among oncogenic signaling pathways.The enhanced toxicity of free small molecule inhibitor combinations is considered an insurmountable barrier to their clinical applications.To circumvent this issue,we rationally designed an effective tumor microenvironment-activatable prodrug nanomicelle(PNM)for cancer therapy.PNM was engineered by integrating the PI3K/m TOR inhibitor PF-04691502(PF)and the broad spectrum CDK inhibitor flavopiridol(Flav)into a single nanoplatform,which showed tumor-specific accumulation,activation and deep penetration in response to the high glutathione(GSH)tumoral microenvironment.The codelivery of PF and Flav could trigger gasdermin E(GSDME)-based immunogenic pyroptosis of tumor cells to elicit a robust antitumor immune response.Furthermore,the combination of PNM-induced immunogenic pyroptosis with antiprogrammed cell death-1(a PD-1)immunotherapy further boosted the antitumor effect and prolonged the survival time of mice.Collectively,these results indicated that the pyroptosis-induced nanoplatform codelivery of PI3K/m TOR and CDK inhibitors can reprogram the immunosuppressive tumor microenvironment and efficiently improve checkpoint blockade cancer immunotherapy. 展开更多
关键词 PYROPTOSIS PRODRUG STIMULI-RESPONSIVE IMMUNOTHERAPY Targeted therapy Tumor microenvironment
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部